Robert Floyd Email & Phone Number

Robert A. Floyd, PhD 1988-present; Extensive biotechnology experience; Research lead to intellectual property basis of 4 biotech companies.1987-2007; Head of Free Radical Biology and Aging Research Program at Oklahoma Medical Research Foundation. 1974-2013; PI of NIH-funded basic research grants and PI and co-PI of DOD–funded grants which led to discoveries and major patents. Published 230+ scientific papers,48 book chapters. IP:25 primary patents lead to follow-on patents; 5 new patents in development. Awards: 2007 Recipient of the Society of Free Radical Biology Medicine’s “Discovery Award” ; 1996 Top Research Award and Gold Medal, American Aging Association; 1992, Best Aging Research Award; Glenn Foundation for Medical Research;1983-87,Biotechnology:CentaurPharmaceuticals,Inc- 1992-2000;Scientific discoveries came from Floyd lab. Floyd was Co-Founder. Centaur conducted R&D on novel nitrone compounds for acute ischemic stroke. Lead compound was NXY-059-partnered with AstraZeneca-drug developed through phase 1, 2 and 3 clinical trials for acute ischemic stroke. Onconos, Inc.-2006-2009;Principle discoveries leading to primary IP out of Floyd lab. Co-founder of the company existed as private virtual company within OMRF. IND submitted in May 2012 to treat Glioblastoma. First clinical trials started in October 2012. Patented technology now licensed to a Korean company. Otologic Pharmaceutics, Inc.-2010-present; Dr. Floyd is a co-founder. The IP arose from discoveries of the ONR-funded research in the Floyd lab and Dr. R. Kopke lab at Hough Ear Institute. Otologic Pharmaceuticals, Inc. merged with Accele BioPharma, Inc. 2014.Clinical trials phase 1 and phase 1b completed 2015. Plans to start phase 2 efficacy trials 2016. EpimedX, LLC-2011-present; Floyd is a co-founder along with Dr. Robert Broyles. Floyd is Chief Operating Officer and Broyles Chief Scientific Officer. EpimedX conducts R&D using novel Gene Regulation Therapy compounds to treat Sickle Cell Disease.

Listed skills include Research, Molecular Biology, Science, Immunology, and 16 others.